Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New Treatment Protocol Increases Survival Of Very Young Infants With Acute Lymphoblastic Leukemia

20.07.2007
A new treatment protocol for infants under one-year with acute lymphoblastic leukaemia (ALL) has shown increased survival compared to conventional regimens. The findings are reported in an Article published in this week’s edition of The Lancet.

ALL in infants aged younger than 12 months is both rare and biologically different from ALL in older children. Although the cure rate in children with ALL has improved from around 10% 40 years ago to 80% currently, this improved cure rate has not been seen in infants under 12-months, where event-free survival (EFS) has been reported in the range 17-45%.

Dr Rob Pieters, Erasmus MC-Sophia Childrens Hospital, Rotterdam, The Netherlands and colleagues did a study of 482 infants from 22 countries aged under one-year – The Interfant-99 trial. The patients were arranged in risk-order following their peripheral blood response to a 7-day prednisone pre-treatment (prednisone is a standard ALL treatment). They were then given a hybrid treatment regimen based on the standard treatment protocol for ALL, incorporating some elements designed for treatment of acute myeloid leukaemia (AML).

With an average follow-up time of just over three years, the researchers found that 58% of patients who received the hybrid treatment were in complete remission, while at four years follow-up 47% had experienced EFS. In previous studies of ALL, EFS has been reported in the range 17-45%. The hybrid treatment protocol did not produce more toxic effects than in previous regimens. The authors say: “Patients treated with our hybrid protocol, and especially those who responded poorly to prednisone, had higher EFS than most reported outcomes for treatment of infant ALL.”

The authors believe that the use of cytarabine in low-dose and high-dose sequential course could have led to the improved outcomes in Interfant-99. In-vitro studies have shown that infant lymphoblasts are highly sensitive to cytarabine.

The authors conclude: “We believe that this hybrid treatment protocol will be used as the standard for continuing international collaborative studies that aim to further improve outcomes for acute lymphoblastic leukaemia in infants.”

In an accompanying Comment, Dr Josep-Maria Ribera and Dr Albert Oriol, Institut Català d’Oncologia-Hospital Universitari Germans Trias I Pujol, Badalona, Spain, say “Despite the good results of the Interfant-99 protocol, there is a long way to go....new strategies, mainly derived from knowledge of the disease at a genomic level, are urgently needed. They will lead to the development of novel agents that will hopefully be integrated within the current cytarabine-based strategies. To achieve this goal, international collaboration must continue in this rare leukaemia.”

Tony Kirby | alfa
Further information:
http://www.thelancet.com/webfiles/images/clusters/thelancet/press_office/Lymphoblastic.pdf

More articles from Health and Medicine:

nachricht New malaria analysis method reveals disease severity in minutes
14.08.2017 | University of British Columbia

nachricht New type of blood cells work as indicators of autoimmunity
14.08.2017 | Instituto de Medicina Molecular

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

A Map of the Cell’s Power Station

18.08.2017 | Life Sciences

Engineering team images tiny quasicrystals as they form

18.08.2017 | Physics and Astronomy

Researchers printed graphene-like materials with inkjet

18.08.2017 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>